Literature DB >> 11421870

Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials.

G F Longstreth1, C J Hawkey, E A Mayer, R H Jones, J Naesdal, I K Wilson, R A Peacock, I K Wiklund.   

Abstract

BACKGROUND: Variation in the characteristics of irritable bowel syndrome patients recruited for clinical trials from different sources could affect their response and the generalizability of trial results. AIM: To describe and compare the characteristics of three different groups of irritable bowel syndrome patients recruited into a 'mock clinical trial.'
METHODS: We enrolled 245 irritable bowel syndrome patients from three sources: (i) 121 from British primary practitioners; (ii) 72 from California newspaper advertisements; and (iii) 52 from a California gastroenterologist's practice. We obtained demographic, clinical, and Hospital Anxiety and Depression (HAD) Scale data.
RESULTS: Most patients were young to middle-aged women; the majority reported symptoms for > 5 years in all three groups. Subject characteristics varied among the groups. Typically, primary care patients were anxious, smokers and daily alcohol drinkers who had sought care recently for irritable bowel syndrome and tried antispasmodic drugs. Their symptoms were intermediate in severity between those of the other two groups. Advertisement subjects were the oldest, most highly educated, most often depressed, and were least likely to have sought care recently for symptoms, which were almost uniformly only moderate in severity. Gastroenterologist patients tended to be anxious and had nearly all sought care recently for symptoms, which were the most severe and most likely to include all three pain-related Rome I criteria.
CONCLUSION: Recruitment methodology affects important characteristics of an irritable bowel syndrome study group.

Entities:  

Mesh:

Year:  2001        PMID: 11421870     DOI: 10.1046/j.1365-2036.2001.01010.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  31 in total

1.  How to read a clinical trial paper: a lesson in basic trial statistics.

Authors:  Shail M Govani; Peter D R Higgins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

2.  Chronic diarrhoea.

Authors:  R Spiller
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

Review 3.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

4.  ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS.

Authors:  Sam-Ryong Jee; Walter Morales; Kimberly Low; Christopher Chang; Amy Zhu; Venkata Pokkunuri; Soumya Chatterjee; Edy Soffer; Jeffrey L Conklin; Mark Pimentel
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 5.  IBS and IBD - separate entities or on a spectrum?

Authors:  Robin Spiller; Giles Major
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-26       Impact factor: 46.802

6.  Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS).

Authors:  M Kanazawa; O S Palsson; M A L van Tilburg; L M Gangarosa; S Fukudo; W E Whitehead
Journal:  Neurogastroenterol Motil       Date:  2014-02-13       Impact factor: 3.598

Review 7.  New developments in the diagnosis and treatment of irritable bowel syndrome.

Authors:  George F Longstreth; Douglas A Drossman
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 8.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule.

Authors:  Rok Seon Choung; G Richard Locke; Alan R Zinsmeister; Cathy D Schleck; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

Review 10.  Is irritable bowel syndrome an inflammatory disorder?

Authors:  Roberto De Giorgio; Giovanni Barbara
Journal:  Curr Gastroenterol Rep       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.